switching from compounded semaglutide to zepbound a a brand-name GLP-1? Here's how to do it in 5 steps Transition to Branded Weight Loss

Eur J Pharm Sci 104:3141

Neuroprotective Effects Emerging research suggests GLP-1 medications may have neuroprotective properties, potentially benefiting cognitive function and reducing the risk of neurodegenerative diseases like Alzheimers

This includes past thyroid conditions, gastrointestinal disorders, or interactions with other medications

The real-world results we see in clinic come from combining a GLP-1 medication with structured nutrition advice, regular weighing-in, and a clinician available to manage side effects

The FDA has expressed several concerns that many of these compounded products: are marketed like FDA-approved drugs

People from some ethnic backgrounds (like South Asian or Black African, Caribbean, Middle Eastern, other specific ethnic backgrounds) may qualify at a lower BMI ( reduced by 2.5 kg/m2 ) because their health risks start at a lower weight